• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD PHASEAL¿CONNECTOR; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD PHASEAL¿CONNECTOR; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 515202
Device Problem Leak/Splash (1354)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/27/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(6).A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that bd phaseal¿connector leaked.No serious injury or medical intervention was reported.
 
Event Description
It was reported that bd phaseal¿connector leaked.No serious injury or medical intervention was reported.
 
Manufacturer Narrative
Investigation summary: fifty-seven sample units belonging to lot number 1707001 were received for evaluation by our quality engineer.A device history record review was performed on the provided lot number and no quality issues were found during the production process that may have contributed to the reported incident.Investigation conclusion: visual inspection was performed on the returned samples and no defects were observed.Leakage testing was performed on twenty of the returned samples and no signs of leakage were found through the phaseal membrane.Five of the samples were connected to infusions sets and the connectors worked per specification with no signs of leakage.Root cause description: based on the investigation results, the reported incident could not be replicated and therefore, an exact cause for the reported incident could not be determined.Rationale: the performance of the sealing membrane is reduced after multiple perforations and extended activation time.It is recommended that no more than ten perforations are performed.Complaints received for this defect and device will be monitored by our quality team for signs of emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL¿CONNECTOR
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
MDR Report Key8196497
MDR Text Key131497515
Report Number3003152976-2018-00563
Device Sequence Number1
Product Code ONB
UDI-Device Identifier30382905152024
UDI-Public30382905152024
Combination Product (y/n)N
PMA/PMN Number
K123213
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 01/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date06/30/2021
Device Catalogue Number515202
Device Lot Number1707001
Initial Date Manufacturer Received 12/10/2018
Initial Date FDA Received12/26/2018
Supplement Dates Manufacturer Received12/10/2018
Supplement Dates FDA Received01/16/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-